Search results for: Amanda Cole
Filter search results
The Dynamics of Drug Shortages
9 January 2024
Share this: Download publication Matthew Napier Dimitrios Kourouklis Amanda Cole Graham Cookson Drug shortages are an industry-wide problem. Numerous factors may be considered as contributing to drug shortages across the…
No cure, no fee?
25 September 2023
Discover key takeaways from @ProgressEduTrust’s article by @nadine_h22 & @Amanda_M_Cole about outcome-based agreements for gene therapies. Read more on X….
The commercial case for investing in ALS
13 November 2025
Share this: Download publication Brittany Darrow Priscila Radu Amanda Cole Key takeaways Unmet need: Diagnosis is often delayed, and few disease-modifying therapies exist, offering only modest benefits or limited applicability…
A Framework for Value-aligned Pricing of Combination Therapies
25 June 2024
Share this: Download publication Matthew Napier Chris Sampson Amanda Cole Martina Garau Combination therapies can provide effective treatment options and improve patient outcomes. However, there are significant barriers to patient…
The Cost of Drug Shortages
16 September 2024
Share this: Download publication Matthew Napier Mikel Berdud Amanda Cole Across the globe, drug shortages are becoming increasingly common. Key takeaways Drug shortages are a growing global concern, affecting multiple…
Employer Costs from Respiratory Infections
16 December 2024
Share this: Download publication Helen Hayes Brittany Darrow Lotte Steuten Graham Cookson Amanda Cole Our latest research shows respiratory infections cost UK businesses £44 billion a year. Workplace vaccination programs…
The Importance of Diversity of Supply in Rare Diseases Markets
23 January 2025
Share this: Download publication Matthew Napier Brittany Darrow Matthias Hofer Mikel Berdud Amanda Cole Rare disease medicine markets often rely on single suppliers, increasing the risk of shortages and limiting…
Our team
…Affairs Tim Watson Director of Marketing and Communications Amanda Cole Director Grace Hampson Director David Mott Associate Director Our economists Mikel Berdud Senior Principal Economist Chris Sampson Senior Principal Economist…
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?
1 June 2022
Share this: Download publication Sian Hodgson Nadine Henderson Adrian Towse Amanda Cole Gene therapies represent a new era of medicine, offering the potential for truly transformational health gains, and further…